Urovant may be gearing up for its first commercial launch, but that doesn’t mean it’s taking its eye off the R&D ball. As it builds its commercial organization for its overactive bladder treatment, ...

Astellas tapped independent agency Roska Healthcare as consumer agency-of-record for Astellas’ new overactive bladder pill, Myrbetriq (mirabegron). The agency announced the win in August, just over a ...

TOKYO, May 7, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has approved ...

TOKYO, June 29, 2017 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today the submission of a supplemental New Drug Application (sNDA) to ...

The Food and Drug Administration approved a new indication for Astellas’ Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension). The ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • I’m a 33-year-old woman with an overactive bladder. It was keeping me awake at night with painful spasms telling ...

Angie always assumed her frequent trips to the restroom to pee were normal. It wasn’t until she hit her 20s and started working in an office with other women that she started to question whether the ...

The beta-3 adrenergic agonist mirabegron (Myrbetriq) gained an indication for neurogenic detrusor overactivity (NDO), a form of bladder dysfunction, in children 3 and older, the FDA announced Thursday ...

The US Food and Drug Administration (FDA) has expanded the indication for Mirabegron (Myrbetriq/Myrbetriq Granules) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to ...

Myrbetriq is a brand-name prescription that helps to treat bladder conditions, such as overactive bladder. What are the out-of-pocket costs for Myrbetriq? There are various factors that can affect the ...

(BPT) - You get that urge to pee and you know it's time to go. You find the nearest restroom and then continue on your day. Not much later though, you feel that same urge. Once again, you go to the ...

TOKYO, March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA) approved ...